Brief: Lexicon Pharmaceuticals Provides Business And Pipeline Update

Lexicon Pharmaceuticals

08/01/2024 14:02

Jan 8 (Reuters) - Lexicon Pharmaceuticals Inc  LXRX.O :
    * LEXICON PHARMACEUTICALS PROVIDES BUSINESS AND PIPELINE
UPDATE AT
42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
    * LEXICON PHARMACEUTICALS INC- INPEFA(®) LAUNCH POSITIONED
FOR
ACCELERATION IN 2024
    * LEXICON PHARMACEUTICALS INC- LX9211 LATE-STAGE DEVELOPMENT
UNDERWAY
    * LEXICON PHARMACEUTICALS INC- EXPECTS CONTINUED
PRESCRIPTION AND
NET SALES GROWTH THROUGHOUT YEAR, ACCELERATING IN SECOND HALF OF
2024 FOR INPEFA
    * LEXICON PHARMACEUTICALS INC- PATIENT ENROLLMENT IN
PROGRESS
PHASE 2B STUDY IS NOW UNDERWAY, WITH DATA ANTICIPATED IN Q2 2025
FOR LX9211

Source text for Eikon:  ID:nGNX1HVCK1 
Further company coverage:  LXRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))